Home » Stocks » RCHR

ArcherDX, Inc. (RCHR)

ArcherDX was planning to go public, but the IPO has been withdrawn.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) 55.91M
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a


There are no news available yet.

About RCHR

ArcherDX is a leading genomics company democratizing precision oncology. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. This empowers clinicians to control the sample, data, patient care and economics. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development. We believe these benefits will drive broader adoption of precision oncology throughout the therapeutic continuum, improving patient care. Our produ... [Read more...]

IPO Date
Jason Myers
Stock Exchange
Ticker Symbol
Full Company Profile